AIDS Therapies
IL-16 Gene Therapy Makes CD4+ T Cells Resistant to HIV
Published in Gene Therapy Weekly, August 4th, 1997
While exogenous IL-16 inhibits HIV replication by 70 to 90 percent, constitutive expression of 1,000-fold smaller amounts of the cytokine by genetically engineered CD4+ cells inhibited viral replication by as much as 99 percent.
"In the long term, gene therapy might be used to introduce IL-16 cDNA (perhaps with other anti-HIV genes) into CD4+ stem cells from HIV infected patients, before these stem cells give rise to CD4+ HIV susceptible cells, and render them resistant to HIV infection," suggested Paul Zhou and colleagues of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1997-08-04)
More Articles from Gene Therapy Weekly
- Cancer Therapy
The Integrin-Activating Antibody TS2/16 Enhances Adenovirus Infection - AIDS Pathogenesis
HIV Self-Perpetuation: A New Vaccine/Drug Target? - AIDS Vaccines
Friend Virus Provides Model for HIV Immunity - Autoimmune Disease
Tolerance Induced by Eating Plants Expressing Autoantigen - Breast Cancer (Genetics)
Scientists Identify A Tumor Suppressor Gene Implicated In Breast Cancer - Clinical Trials
Enrollment Sought in Pilot Study of Lymphoma Vaccine - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
